Wells Fargo analyst Stephen Baxter raised the firm’s price target on UnitedHealth to $630 from $561 and keeps an Overweight rating on the shares following “solid” Q3 results. The firm continues to see UnitedHealth as well positioned to achieve estimates in 2024 and well-insulated from the current macro / GLP-1 overhangs on many other sectors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on UNH:
- UBS upgrades UnitedHealth to Buy after ‘clearing event’
- UnitedHealth upgraded to Buy from Neutral at UBS
- Evercore ISI says CVS ‘big winner’ as Med Adv star quality ratings go live
- UnitedHealth Stock (NYSE:UNH): Beat-and-Raise is What the Doctor Ordered
- Unusually active option classes on open October 13th